世界の血液診断市場の規模は2023年に75億4000万ドルと評価され、2024年から2030年にかけて6.5%のCAGRで成長すると予測されます。貧血、白血病、リンパ腫、骨髄腫などの血液疾患や血液悪性腫瘍の有病率の増加がこの市場の主な成長要因です。これらの状態には、正確でタイムリーな診断手順が必要であり、血液診断はそれを提供することが可能です。これらの疾患を効果的に治療・管理するためには、早期発見と正確な診断が不可欠であり、高度な診断ツールの必要性が高まっています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hematology Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Hematology Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Hematology Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hematology Diagnostics Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Instrument
4.3.1. Instrument Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.2. Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.3. Flow Customers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.4. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Consumables
4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.2. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.3. Stains Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.4. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Hematology Diagnostics Market: Test Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hematology Diagnostics Market: Test Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Blood Count
5.3.1. Blood Count Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Platelet Function
5.4.1. Platelet Function Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Hemoglobin
5.5.1. Hemoglobin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Hematocrit
5.6.1. Hematocrit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Hematology Diagnostics Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Hematology Diagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Diagnostic labs
6.4.1. Diagnostics labs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Hematology Diagnostics Market: Regional Estimates & Trend Analysis
7.1. Hematology Diagnostics Market Share, By Region, 2023 & 2030, USD Billion,
7.2. North America
7.2.1. North America Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.2. U. S.
7.2.2.1. U. S. Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.3. Canada
7.2.3.1. Canada Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.4. Mexico
7.2.4.1. Mexico Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. Europe Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.2. UK
7.3.2.1. UK Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.3. Germany
7.3.3.1. Germany Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.4. France
7.3.4.1. France Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.5. Italy
7.3.5.1. Italy Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.6. Spain
7.3.6.1. Spain Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.7. Denmark
7.3.7.1. Denmark Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.8. Sweden
7.3.8.1. Sweden Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.9. Norway
7.3.9.1. Norway Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.2. China
7.4.2.1. China Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.3. India
7.4.3.1. India Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.4. Japan
7.4.4.1. Japan Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.5. Australia
7.4.5.1. Australia Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.6. South Korea
7.4.6.1. South Korea Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Thailand Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. Latin America Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion), (Volume in Kilotons)
7.5.2. Brazil
7.5.2.1. Brazil Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5.3. Argentina
7.5.3.1. Argentina Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.2. South Africa
7.6.2.1. South Africa Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.4. UAE
7.6.4.1. UAE Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.5. Kuwait
7.6.5.1. Kuwait Hematology Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Abbbott
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Beckman Coulter
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Sysmex Corporation
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Horiba
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Bio-Rad Laboratories
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Siemens Healthineers AG
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. F. Hoffmann-La Roche Ltd
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. NIHON KOHDEN CORPORATION.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. EKF Diagnostics
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
